Fecal Microbiota Preparation MTP-101C clinical trials
Also written MTP-101C.
How each study uses Fecal Microbiota Preparation MTP-101C is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Fecal Microbiota Preparation MTP-101C studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2025 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2025 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 6
VA Office of Research and Development (1) · Melana Yuzefpolskaya, MD (1) · University of Minnesota (1) · Duke University (1) · University of Wisconsin, Madison (1) · Diwakar Davar (1)
Often tested with
Tested in the same studies.
MTP-101S (1) · Vancomycin (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test Fecal Microbiota Preparation MTP-101C.
- Nov 2026Intestinal Microbiome Transplant in ALSPhase 1/2 · Duke University
- Sep 2027Intestinal Microbiota Transplantation in Patients With Chronic Heart FailurePhase 1 · Melana Yuzefpolskaya, MD
Studies
Open first, then newest update. How each study uses Fecal Microbiota Preparation MTP-101C is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Intestinal Microbiota Transplantation in Patients With Chronic Heart FailureRecruitingPhase 1Melana Yuzefpolskaya, MDNCT07490054Written as MTP-101-C encapsulated Microbiota
- Standardized Microbiota Transplant Therapy in Crohn's DiseaseRecruitingPhase 2University of MinnesotaNCT06631586Written as MTP-101C
- Intestinal Microbiome Transplant in ALSRecruitingPhase 1/2Duke UniversityNCT07017946Written as MTP-101C
- Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE)Not yet recruitingPhase 2VA Office of Research and DevelopmentNCT07528690Written as Microbiota transplant therapy (MTT) capsules
- Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC)WithdrawnPhase 2Diwakar DavarNCT06499896Written as MTP-101-C
- Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant RecipientsTerminatedPhase 2University of Wisconsin, MadisonNCT03617445Written as FMT oral capsule